BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22968139)

  • 1. Misoprostol for preventing and treating postpartum hemorrhage in the community: a closer look at the evidence.
    Oladapo OT
    Int J Gynaecol Obstet; 2012 Nov; 119(2):105-10. PubMed ID: 22968139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Misoprostol for the prevention and treatment of postpartum hemorrhage.
    Sheldon WR; Blum J; Durocher J; Winikoff B
    Expert Opin Investig Drugs; 2012 Feb; 21(2):235-50. PubMed ID: 22233426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Misoprostol for prevention and treatment of postpartum hemorrhage: what do we know? What is next?
    Raghavan S; Abbas D; Winikoff B
    Int J Gynaecol Obstet; 2012 Oct; 119 Suppl 1():S35-8. PubMed ID: 22883912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral misoprostol for preventing postpartum haemorrhage in home births in rural Bangladesh: how effective is it?
    Hashima-E-Nasreen ; Nahar S; Al Mamun M; Afsana K; Byass P
    Glob Health Action; 2011; 4():. PubMed ID: 21845143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of postpartum hemorrhage with misoprostol.
    Blum J; Alfirevic Z; Walraven G; Weeks A; Winikoff B
    Int J Gynaecol Obstet; 2007 Dec; 99 Suppl 2():S202-5. PubMed ID: 17961565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postpartum hemorrhage prevention in Nepal: a program assessment.
    Rajbhandari SP; Aryal K; Sheldon WR; Ban B; Upreti SR; Regmi K; Aryal S; Winikoff B
    BMC Pregnancy Childbirth; 2017 Jun; 17(1):169. PubMed ID: 28583092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advance distribution of misoprostol for prevention of postpartum hemorrhage (PPH) at home births in two districts of Liberia.
    Smith JM; Baawo SD; Subah M; Sirtor-Gbassie V; Howe CJ; Ishola G; Tehoungue BZ; Dwivedi V
    BMC Pregnancy Childbirth; 2014 Jun; 14():189. PubMed ID: 24894566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in low-risk women.
    Chaudhuri P; Biswas J; Mandal A
    Int J Gynaecol Obstet; 2012 Feb; 116(2):138-42. PubMed ID: 22100204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations for scale-up of community-based misoprostol distribution programs.
    Robinson N; Kapungu C; Carnahan L; Geller S
    Int J Gynaecol Obstet; 2014 Jun; 125(3):285-8. PubMed ID: 24680582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initiating a novel therapy in preventing postpartum hemorrhage in rural India: a joint collaboration between the United States and India.
    Kodkany BS; Derman RJ; Goudar SS; Geller SE; Edlavitch SA; Naik VA; Patel A; Bellad MB; Patted SS
    Int J Fertil Womens Med; 2004; 49(2):91-6. PubMed ID: 15188836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction of misoprostol for prevention of postpartum hemorrhage at the community level in Senegal.
    Diadhiou M; Dieng T; Ortiz C; Mall I; Dione D; Sloan NL
    Int J Gynaecol Obstet; 2011 Dec; 115(3):251-5. PubMed ID: 21982859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New global guidance supports community and lay health workers in postpartum hemorrhage prevention.
    Ejembi CL; Norick P; Starrs A; Thapa K
    Int J Gynaecol Obstet; 2013 Sep; 122(3):187-9. PubMed ID: 23796260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interpretation of national policy regarding community-based use of misoprostol for postpartum hemorrhage prevention in Ethiopia: a tale of two regions.
    Spangler SA; Gobezayehu AG; Hailemariam TG; Sibley LM
    J Midwifery Womens Health; 2014 Jan; 59 Suppl 1():S83-90. PubMed ID: 24588920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Misoprostol: off-label use in the treatment of post-partum hemorrhage].
    Garrigue A; Pierre F
    J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):179-89. PubMed ID: 24457021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community-based distribution of misoprostol to prevent postpartum haemorrhage at home births: results from operations research in rural Ghana.
    Geller S; Carnahan L; Akosah E; Asare G; Agyemang R; Dickson R; Kapungu C; Owusu-Ansah L; Robinson N; Mensah-Homiah J
    BJOG; 2014 Feb; 121(3):319-25. PubMed ID: 24283350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing a home-based model of care using misoprostol for prevention and treatment of postpartum hemorrhage: results from a randomized placebo-controlled trial conducted in Badakhshan province, Afghanistan.
    Abbas DF; Mirzazada S; Durocher J; Pamiri S; Byrne ME; Winikoff B
    Reprod Health; 2020 Jun; 17(1):88. PubMed ID: 32503556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Misoprostol for the management of postpartum bleeding: a new approach.
    Dabash R; Blum J; Raghavan S; Anger H; Winikoff B
    Int J Gynaecol Obstet; 2012 Dec; 119(3):210-2. PubMed ID: 22980431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of postpartum hemorrhage with misoprostol.
    Alfirevic Z; Blum J; Walraven G; Weeks A; Winikoff B
    Int J Gynaecol Obstet; 2007 Dec; 99 Suppl 2():S198-201. PubMed ID: 17961574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misoprostol: preventing postpartum haemorrhage.
    Walder J
    Mod Midwife; 1997 Sep; 7(9):23-7. PubMed ID: 9370621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cluster-randomized, non-inferiority trial comparing use of misoprostol for universal prophylaxis vs. secondary prevention of postpartum hemorrhage among community level births in Egypt.
    Anger HA; Dabash R; Hassanein N; Darwish E; Ramadan MC; Nawar M; Charles D; Breebaart M; Winikoff B
    BMC Pregnancy Childbirth; 2020 May; 20(1):317. PubMed ID: 32448257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.